drugset

drugset / Trial / NCT02042599

Pharmacokinetic Study of 48-hour Sevoflurane Inhalation Using a Disposable Delivery System (AnaConDa©) in ICU Patients With Acute Kidney Injury

NCT02042599 ↗

Phase 2 Unknown 12 enrolled University Hospital, Clermont-Ferrand

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Describing a pharmacokinetic model of 48-h sevoflurane sedation in ICU patients with acute kidney failure

Timeline

Start: 2014-01
Primary completion: 2016-02
Completion: 2016-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sevoflurane	Other / unclassified	—	Inhaled

Indications